CJA Duncan, AVS Hill - BMJ: British Medical Journal (Online), 2011 - search.proquest.com
RTS, S is thought to reduce the risk of infection from each exposure, rather than conferring" all or nothing" protection on a proportion of recipients. 5 By this hypothesis, everyone …
The initial results of the phase III clinical trial for RTS, S—currently the leading malaria vaccine candidate—were recently announced, 1 amid international media coverage …
This thesis is divided into two parts, assessing marine and synthetic compounds active firstly against Plasmodium falciparum (Chapter 3 and 4) and secondly active against methicillin …